In another study GB1107 was shown to increase the response to anti-PD-L1 therapy in a human xenograft model of NSCLC following transplant with human peripheral blood monocytic cells (PBMCs) (15). This evidence concerns the gene CD274 and non-small cell lung carcinoma.